Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|5|6|527-532

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.5, Iss.6, 2005-12, pp. : 527-532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 541-548

Bentham Science Publishers

Access to resources Recommend Favorite

Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 4, 2005-08 ,pp. : 303-311

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein(a) is a Therapeutic Target for Cardiovascular Disease

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 118-121

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein E: Possible Therapeutic Target for Atherosclerosis

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 1, Iss. 2, 2001-12 ,pp. : 93-106

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein Cholesterol and Atherosclerosis

By  

Current Molecular Medicine, Vol. 1, Iss. 6, 2001-12 ,pp. : 633-653

Bentham Science Publishers

Access to resources Recommend Favorite